Short answer
Stereotaxis, Inc. (STXS) filed its Q3 2025 10-Q quarterly report on Nov 12, 2025 for the quarter ended Sep 30, 2025. Quarterly revenue was $7M (down 18.8% year over year) with net income of −$6M.
Q3 2025 key financials · XBRL
- Revenue
- $7M
- −18.8% YoY · −15.2% QoQ
- Net income
- −$6M
- −4.4% YoY · −68.9% QoQ
- Operating margin
- -87.8%
- Gross margin
- 54.9%
- EPS (diluted)
- −$0.07
- +12.5% YoY · −40.0% QoQ
Source: XBRL data from the Stereotaxis, Inc. (STXS) Q3 2025 10-Q on SEC EDGAR. USD.
Stereotaxis, Inc. Q3 2025 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Outlook risks: APT acquisition impacts, regulatory uncertainty, and lengthy approval processes
Risk Factors
- No material changes reported to 10-K risk factors
- Regulatory milestone achieved, triggering issuance of 417,710 shares to APT Holding
- Resale registration covers up to 6,100,000 APT Holding shares
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Stereotaxis, Inc. quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.